Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia : in vitro effects and clinical efficacy in cancer patients | Zendy

Hideki Araoka | Zendy; Masaru Baba | Zendy; Chikako Okada | Zendy; Masahiro Abe | Zendy; Muneyoshi Kimura | Zendy; Akiko Yoneyama | Zendy

Open Access

Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia : in vitro effects and clinical efficacy in cancer patients

Author(s) -

Hideki Araoka,

Masaru Baba,

Chikako Okada,

Masahiro Abe,

Muneyoshi Kimura,

Akiko Yoneyama

Publication year - 2017

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2017.02.020

Subject(s) - stenotrophomonas maltophilia , levofloxacin , medicine , ticarcillin , sulfamethoxazole , clavulanic acid , minocycline , trimethoprim , antimicrobial , microbiology and biotechnology , antibiotics , amoxicillin , pseudomonas aeruginosa , biology , bacteria , genetics

The aim of this study was to evaluate the in vitro effects and clinical efficacies of trimethoprim-sulfamethoxazole (SXT) combined with other antimicrobial agents against Stenotrophomonas maltophilia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research